Sophie Young
Chicago Department of Public Health(US)University of Illinois Chicago(US)Kings Health Partners(GB)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Adolescent Sexual and Reproductive Health, Heart Failure Treatment and Management, Mental Health Treatment and Access
Most-Cited Works
- → Discontinuation vs. continuation of renin–angiotensin system inhibition before non-cardiac surgery: the SPACE trial(2023)62 cited
- → Characteristics and outcomes of patients with COVID-19 at high-risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England(2022)24 cited
- → Preoperative N-terminal pro-B-type natriuretic peptide and myocardial injury after stopping or continuing renin–angiotensin system inhibitors in noncardiac surgery: a prespecified analysis of a phase 2 randomised controlled multicentre trial(2024)11 cited
- → Care pathways, prescribing practices and treatment outcomes in major depressive disorder and treatment-resistant depression: retrospective, population-based cohort study(2024)10 cited
- → Health-care utilisation and associated economic burden in major depressive disorder and treatment-resistant depression in a longitudinal population-based cohort study of 110.000 patients(2024)8 cited
- → Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study(2024)8 cited
- → Evaluation of prototype risk prediction tools for clinicians and people living with type 2 diabetes in North West London using the think aloud method(2023)5 cited
- → Evaluation of large language models within GenAI in qualitative research(2025)5 cited
- → “Whenever I help her, I am also expecting her vagina in return”: a qualitative analysis to explore men’s and adolescent girls’ perceptions of the impact of the COVID-19 pandemic on the sexual behaviour and health of adolescent girls in rural western Kenya(2024)3 cited
- → Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study(2024)3 cited